Literature DB >> 3944748

Laboratory assessment of disease activity in childhood Crohn's disease and ulcerative colitis.

P I Macfarlane, V Miller, F Wells, B Richards.   

Abstract

The erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and serum orosomucoid were measured in children with Crohn's disease and ulcerative colitis in various states of disease activity. Results were matched with a clinical assessment to determine the correlation between laboratory test values and disease activity. Regression analysis showed that serum orosomucoid reflected disease activity better than ESR in both diseases. Orosomucoid but not ESR discriminated between disease in remission and mild disease in ulcerative colitis. No test invariably predicted presence or absence of active disease. Orosomucoid and ESR were complementary, but CRP was of no additional value. The usefulness of orosomucoid and ESR as objective measures of inflammatory activity was not masked by corticosteroid medication.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3944748     DOI: 10.1097/00005176-198601000-00017

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  6 in total

Review 1.  MR enterography: how to deliver added value.

Authors:  Jonathan R Dillman; Andrew T Trout; Ethan A Smith
Journal:  Pediatr Radiol       Date:  2016-03-03

2.  Predicting relapses of Crohn's disease. Clouds in the crystal ball.

Authors:  D B Sachar
Journal:  Dig Dis Sci       Date:  1987-02       Impact factor: 3.199

Review 3.  Laboratory assessment of inflammatory bowel disease.

Authors:  I T Beck
Journal:  Dig Dis Sci       Date:  1987-12       Impact factor: 3.199

4.  Indications for investigation of chronic gastrointestinal symptoms.

Authors:  R M Beattie; J A Walker-Smith; S H Murch
Journal:  Arch Dis Child       Date:  1995-10       Impact factor: 3.791

5.  C-reactive protein and disease activity in children with Crohn's disease.

Authors:  Samantha Tilakaratne; Daniel A Lemberg; Steven T Leach; Andrew S Day
Journal:  Dig Dis Sci       Date:  2010-01       Impact factor: 3.199

6.  Comparison of Ustekinumab Trough Concentrations Measured by 2 ELISA Kits and Evaluation of Clinical Response in Crohn's Disease.

Authors:  Yiyoung Kwon; Ben Kang; Eun Sil Kim; Yon Ho Choe; Mi Jin Kim
Journal:  Ther Drug Monit       Date:  2022-02-18       Impact factor: 3.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.